Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai‐Dong Zhu, Jian Wang, Hai-Liang Li et al.|Signal Transduction and Targeted Therapy|2023Cited by 295
hGH promotes megakaryocyte differentiation and exerts a complementary effect with c-Mpl ligands on thrombopoiesisYang Xu, Junping Wang, Song Wang et al.|Blood|2014Cited by 38
Data from Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor MalignanciesMelissa Johnson, Alexander I. Spira, Valentina Boni et al.|Unknown|2023Cited by 0
Data from Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor MalignanciesMelissa Johnson, Alexander I. Spira, Anthony B. El-Khoueiry et al.|Unknown|2023Cited by 0